The association between lupus serology and disease outcomes: A systematic literature review to inform the treat-to-target approach in systemic lupus erythematosus.

Kostopoulou, Myrto; Ugarte-Gil, Manuel F; Pons-Estel, Bernardo; van Vollenhoven, Ronald F; Bertsias, George

Kostopoulou, Myrto; Ugarte-Gil, Manuel F; Pons-Estel, Bernardo; van Vollenhoven, Ronald F; Bertsias, George.

Affiliation

Kostopoulou M; Medical School, 393206National and Kapodistrian University of Athens, Athens, Greece.
Ugarte-Gil MF; Rheumatology Department, Hospital Guillermo Almenara Irigoyen, Lima, Peru.
Pons-Estel B; School of Medicine, Universidad Científica del Sur, Lima, Peru.
van Vollenhoven RF; Department of Rheumatology, Grupo Oroño-Centro Regional de Enfermedades Autoinmunes y Reumáticas (GO-CREAR), Santa Fe, Argentina.
Bertsias G; Department of Rheumatology, 571155Amsterdam Rheumatology and Immunology Center, Amsterdam, The Netherlands.

Lupus ; 31(3): 307-318, 2022 Mar.

Article in En | MEDLINE | ID: mdl-35067068

Subject(s)

Lupus Erythematosus, Discoid; Lupus Erythematosus, Systemic; Lupus Nephritis; Antibodies, Antinuclear/blood; Complement C4/immunology; DNA/immunology; Humans; Lupus Erythematosus, Systemic/blood; Lupus Erythematosus, Systemic/complications; Lupus Erythematosus, Systemic/drug therapy; Lupus Nephritis/blood

Key words

autoantibodies; flares; organ damage; remission; treat-to-target

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lupus Nephritis / Lupus Erythematosus, Discoid / Lupus Erythematosus, Systemic Type of study: Clinical_trials / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limits: Humans Language: En Journal: Lupus Year: 2022 Document type: Article

Fulltext

XML

PubMed Links

Search on Google